Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 27 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Hatzimouratidis, Konstantinos  [Clear All Filters]
Journal Article
Buvat, J., Büttner H., Hatzimouratidis K., Vendeira P. A. S., Moncada I., Boehmer M., et al. (2013).  Adherence to initial PDE-5 inhibitor treatment: randomized open-label study comparing tadalafil once a day, tadalafil on demand, and sildenafil on demand in patients with erectile dysfunction.. J Sex Med. 10(6), 1592-602.
Hatzimouratidis, K. (2010).  Can we cure erectile dysfunction?. Eur Urol. 58(2), 249-50.
Kirana, P-S., Papaharitou S., Athanasiadis L., Nakopoulou E., Salpiggidis G., Moysidis K., et al. (2009).  A conceptual framework for the evolution of sexual medicine and a model for the development of alternative sexual health services: 10-year experience of the center for sexual and reproductive health.. J Sex Med. 6(9), 2405-16.
Panteliou, S. D., Tzortzis V., Anagnostopoulos G. T., Sunaric M. M., Sarris J., Hatzimouratidis K., et al. (2012).  Development of a new optical device and its feasibility in prostate cancer detection.. Urol Int. 89(3), 290-5.
Hatzimouratidis, K., Eardley I., Giuliano F., Hatzichristou D., Moncada I., Salonia A., et al. (2012).  EAU guidelines on penile curvature.. Eur Urol. 62(3), 543-52.
Hatzimouratidis, K. (2009).  Editorial comment on: Smooth-muscle-specific gene transfer with the human maxi-K channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys.. Eur Urol. 56(6), 1066.
Anagnostis, P., Papanikolaou D., Ioannidou P. G., Bosdou J. K., Mikhailidis D. P., Hatzimouratidis K., et al. (2021).  The effect of statins on semen parameters in patients with hypercholesterolemia: A systematic review.. Andrology. 9(5), 1504-1511.
Salonia, A., Eardley I., Giuliano F., Hatzichristou D., Moncada I., Vardi Y., et al. (2014).  European Association of Urology guidelines on priapism.. Eur Urol. 65(2), 480-9.
Hatzimouratidis, K., Amar E., Eardley I., Giuliano F., Hatzichristou D., Montorsi F., et al. (2010).  Guidelines on male sexual dysfunction: erectile dysfunction and premature ejaculation.. Eur Urol. 57(5), 804-14.
Hatzimouratidis, K., & Hatzichristou D. (2014).  How to treat erectile dysfunction in men with diabetes: from pathophysiology to treatment.. Curr Diab Rep. 14(11), 545.
Papaefstathiou, E., Apostolopoulou A., Papaefstathiou E., Moysidis K., Hatzimouratidis K., & Sarafis P. (2020).  The impact of burnout and occupational stress on sexual function in both male and female individuals: a cross-sectional study.. Int J Impot Res. 32(5), 510-519.
Papaefstathiou, E., Moysidis K., Sarafis P., Ioannidis E., & Hatzimouratidis K. (2019).  The impact of Diabetes Mellitus on Lower urinary tract symptoms (LUTS) in both male and female patients.. Diabetes Metab Syndr. 13(1), 454-457.
Goulis, D. Ch, Mintziori G., Koliakos N., Hatzichristou D., Papadimas I., Hatzimouratidis K., et al. (2011).  Inhibin B and anti-Müllerian hormone in spermatic vein of subfertile men with varicocele.. Reprod Sci. 18(6), 551-5.
Alexidis, P., Karatzoglou S., Dragoumis D., Drevelegas K., Tzitzikas I., Hatzimouratidis K., et al. (2020).  Late results of a randomized trial on the role of mild hypofractionated radiotherapy for the treatment of localized prostate cancer.. J Cancer. 11(5), 1008-1016.
Eardley, I., Donatucci C., Corbin J., El-Meliegy A., Hatzimouratidis K., McVary K., et al. (2010).  Pharmacotherapy for erectile dysfunction.. J Sex Med. 7(1 Pt 2), 524-40.
Hatzimouratidis, K., Salonia A., Adaikan G., Buvat J., Carrier S., El-Meliegy A., et al. (2016).  Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015).. J Sex Med. 13(4), 465-88.
Hatzimouratidis, K. (2009).  Phosphodiesterase type 5 inhibitors: a viable treatment option for lower urinary tract symptoms?. Expert Opin Investig Drugs. 18(3), 245-54.
Hatzimouratidis, K., Burnett A. L., Hatzichristou D., McCullough A. R., Montorsi F., & Mulhall J. P. (2009).  Phosphodiesterase type 5 inhibitors in postprostatectomy erectile dysfunction: a critical analysis of the basic science rationale and clinical application.. Eur Urol. 55(2), 334-47.
Gkekas, C., Kalyvas V., Symeonidis E. N., Malioris A., Papathanasiou M., Kalinderis N., et al. (2019).  Plexiform Schwannoma of the Penis: A Rare Subtype of Genital Schwannoma.. Case Rep Urol. 2019, 1752314.
Hatzimouratidis, K. (2010).  Re: Penile sonographic and clinical characteristics in men with Peyronie's disease.. Eur Urol. 57(5), 918.
Alexidis, P., Dragoumis D., Karatzoglou S., Drevelegas K., Tzitzikas I., Hatzimouratidis K., et al. (2019).  The role of hypofractionated radiotherapy for the definitive treatment of localized prostate cancer: early results of a randomized trial.. J Cancer. 10(25), 6217-6224.
Papanikolaou, D., Ioannidou P., Koukourikis P., Moysidis K., Meditskou S., Koutsoumparis D., et al. (2020).  Systemic therapy for chromophobe renal cell carcinoma: A systematic review.. Urol Oncol. 38(4), 137-149.
Giuliano, F., Oelke M., Jungwirth A., Hatzimouratidis K., Watts S., Cox D., et al. (2013).  Tadalafil once daily improves ejaculatory function, erectile function, and sexual satisfaction in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia and erectile dysfunction: results from a randomized, placebo- and tamsulosin. J Sex Med. 10(3), 857-65.
Vardi, Y., Levine L. A., Chen J., Hatzimouratidis K., & Sohn M. (2009).  Is there a place for conservative treatment in Peyronie's disease?. J Sex Med. 6(4), 903-9.
Papaefstathiou, E., Apostolopoulou A., Papaefstathiou E., Moysidis K., Hatzimouratidis K., & Sarafis P. (2020).  Urology during a Crisis: A Management Algorithm.. Urol J. 17(5), 536-539.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.